The results of ELISA showed that in contrast to the model group, the IL-6 and IL-1 β expressions in curcumitol treatment or positive drug group manifested a decreasing trend, and the expression level of TNF- α was similar ( Figure 2(c) ). 3.2.
← all excerpts
Curcumol Undermines SDF-1<i>α</i>/CXCR4/NF-<i>κ</i>B Signaling Pathway to Suppress the Progression of Chronic Atrophic Gastritis (CAG) and Gastric Cancer.
1
—
—